3 research outputs found
Statins Impair Antitumor Effects of Rituximab by Inducing Conformational Changes of CD20
Jakub Golab and colleagues found that statins significantly decrease rituximab-mediated complement-dependent cytotoxicity and antibody-dependent cellular cytotoxicity against B cell lymphoma cells